Shared decision-making and deprescribing to support anti-thrombotic therapy (dis)continuance for persons living with cancer in their last phase of life: A realist synthesis
PLOS Medicine · 25.08.2025 · 22 (8) · e1004663
DOI: 10.1371/journal.pmed.1004663 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Medicine, online erschienen am 25.08.2025. Verfasst von Justin Jagosh und 14 weiteren Autor:innen. Beteiligte Einrichtung: Wolfson Palliative Care Research Centre, Hull York Medical School, University of Hull, Hull, United Kingdom. Hauptthemen laut MEDLINE: Neoplasms, Decision Making, Shared, Deprescriptions, Terminal Care. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HORIZON EUROPE Framework Programme, UK Research and Innovation.
Abstract (Originalsprache)
Introduction Patients with cancer are at increased risk of thrombotic complications from both the disease and its treatments, with antithrombotic therapy (ATT) usually continued in the last phase of life where the benefit is less clear and there is high risk of harms. Physiological changes toward the end of life increase the risk that ATT will cause serious bleeding events, but discussion between clinicians and patients of ATT risks and benefits is sub-optimal. This realist synthesis explores shared decision-making (SDM) to: (a) provide insights into why prescribing continues in end-of-life care; (b) build a conceptual platform for optimizing ATT prescribing for persons living with cancer towards end-of-life. Methods and findings We conducted a realist synthesis using context-mechanism-outcome configurations and ‘if…then’ statements. A total of 17,036 citations identified across 10 databases (Medline, EMBASE, APA PsycInfo, CINAHL Complete, CDSR, CENTRAL, EPISTEMONIKOS, Web of Science Core Collection, Assia, Google Scholar). Ninety-one papers included following reverse chronology quota record screening (from: database searches ( n = 56), consortium experts ( n = 35)). Included papers: quantitative ( n = 40), qualitative ( n = 17), mixed-methods ( n = 2), evidence syntheses ( n = 16), commentaries ( n = 9), case reports ( n = 7). Exclusion criteria: persons
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Wolfson Palliative Care Research Centre, Hull York Medical School, University of Hull, Hull, United Kingdom.
- Centre for Advancement in Realist Evaluation and Synthesis (CARES), Vancouver, Canada.
- Hull York Medical School, University of Hull, Hull, United Kingdom.
- Division of Population Medicine, Cardiff University, Cardiff, United Kingdom.
- Danish Center for Health Services Research, Aalborg University Hospital, Aalborg, Denmark.
- Department of Medicine - Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands.
ORCID-Profile: Justin Jagosh, Mark Pearson, Sarah Greenley, Anthony Maraveyas, Gamze Keser, Fliss E M Murtagh, Simon Noble, Adrian Edwards, Anette Arbjerg Højen, Kathy Seddon, Frederikus A Klok, Simon P Mooijaart, Eric C T Geijteman, Miriam J Johnson
Förderung
- HORIZON EUROPE Framework Programme
- UK Research and Innovation
Zitieren
APA
Jagosh, J., Pearson, M., Greenley, S., Maraveyas, A., Keser, G., Murtagh, F. E. M., Noble, S., Edwards, M., Edwards, A., Højen, A. A., Seddon, K., Klok, F. A., Mooijaart, S. P., Geijteman, E. C. T., & Johnson, M. J. (2025). Shared decision-making and deprescribing to support anti-thrombotic therapy (dis)continuance for persons living with cancer in their last phase of life: A realist synthesis. PLOS Medicine, 22(8), e1004663. https://doi.org/10.1371/journal.pmed.1004663
Vancouver
Jagosh J, Pearson M, Greenley S, Maraveyas A, Keser G, Murtagh FEM, et al. Shared decision-making and deprescribing to support anti-thrombotic therapy (dis)continuance for persons living with cancer in their last phase of life: A realist synthesis. PLOS Medicine. 2025;22(8):e1004663. doi:10.1371/journal.pmed.1004663
BibTeX
@article{Jagosh2025,
author = {Jagosh, Justin and Pearson, Mark and Greenley, Sarah and Maraveyas, Anthony and Keser, Gamze and Murtagh, Fliss E M and Noble, Simon and Edwards, Michelle and Edwards, Adrian and Højen, Anette Arbjerg and Seddon, Kathy and Klok, Frederikus A and Mooijaart, Simon P and Geijteman, Eric C T and Johnson, Miriam J},
title = {Shared decision-making and deprescribing to support anti-thrombotic therapy (dis)continuance for persons living with cancer in their last phase of life: A realist synthesis},
journal = {PLOS Medicine},
year = {2025},
volume = {22},
number = {8},
pages = {e1004663},
doi = {10.1371/journal.pmed.1004663}
}
EUVIMED